Amgen projects 2026 revenue of $38.9B-$39.7B and raises non-GAAP EPS guidance
FROM THE WIRE · SEEKINGALPHA.COM
Amgen Q3 2026 earnings: revenue rose 8%, guidance was raised, and IMDELLTRA stood out.
Read at the source ↗MARKET IMPACTNEUTRAL✦ News Impact agent estimateTone: expected bullishA guidance raise from a large biotech company can support the stock and the sector.AI-generated summary
✦ IN BRIEF · AIAI-generated summary
- 01Amgen projects 2026 revenue of $38.9B to $39.7B.
- 02Non-GAAP EPS guidance is raised to $22.90 to $23.70.
- 03Q3 2026 revenue rose 8%, and IMDELLTRA stood out.
NEWS IMPACT AND MARKET REACTIONChange since the story · reference
Impact and summary are estimates by the News Impact AI agent, not financial advice.Open in Markets